Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma harbouring a KHDRBS1-NTRK3 fusion gene

Overview of attention for article published in Frontiers in oncology, February 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 28,032 followers.

RT @Sarcoma_papers: Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma ha…

13 Mar 2023

Reply Repost Favourite

Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma harbouring a KHDRBS1-NTRK3 fusion gene https://t.co/bqhaLAinaB https://t.co/X17rQBbxgt

27 Feb 2023

Reply Repost Favourite

New research: Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma harbouring a KHDRBS1-NTRK3 fusion gene: Significant improvements in the survival rates of paediatric cancer have… https://t.c

27 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.